[Federal Register Volume 65, Number 59 (Monday, March 27, 2000)]
[Notices]
[Pages 16206-16207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-7429]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committees; Notice of Meetings

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a 
tentative schedule of forthcoming meetings of its public advisory 
committees for the remainder of 2000. At the request of the 
Commissioner of Food and Drugs (the Commissioner), the Institute of 
Medicine (the IOM) conducted a study of the use of FDA's advisory 
committees. The IOM recommended that the agency publish an annual 
tentative schedule of its meetings in the Federal Register. In response 
to that recommendation, FDA is publishing its annual tentative 
scheduled meetings for the remainder of 2000.

FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management 
Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-4820.

SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, 
undertook a study of the use of FDA's advisory committees. In its final 
report, the IOM recommended that FDA adopt a policy of publishing an 
advance yearly schedule of its upcoming public advisory committee 
meetings in the Federal Register. FDA has implemented this 
recommendation. A tentative schedule of forthcoming meetings will be 
published annually in the Federal Register. The annual publication of 
tentatively scheduled advisory committee meetings will provide both 
advisory committee members and the public with the opportunity, in 
advance, to schedule attendance at FDA's upcoming advisory committee 
meetings. The schedule is tentative and amendments to this notice will 
not be published in the Federal Register. FDA will, however, publish a 
Federal Register notice 15 days in advance of each upcoming advisory 
committee meeting, announcing the meeting (21 CFR 14.20).
    The following list announces FDA's tentatively scheduled advisory 
committee meetings for the remainder of 2000:

 
------------------------------------------------------------------------
          Committee Names                     Dates of Meetings
------------------------------------------------------------------------
OFFICE OF THE COMMISSIONER
    Science Board to the Food and    April 21
     Drug Administration
CENTER FOR BIOLOGICS EVALUATION AND
 RESEARCH
    Allergenic Products Advisory     October 24
     Committee
    Biological Response Modifiers    March 20-21, October 19-20
     Advisory Committee
    Blood Products Advisory          March 16-17, June 15-16, September
     Committee                        14-15, December 14-15
    Transmissible Spongiform         November 2-3
     Encephalopathies Advisory
     Committee
    Vaccines and Related Biological  May 11-12, July 27-28, September 21-
     Products Advisory Committee      22, November 2-3
CENTER FOR DRUG EVALUATION AND
 RESEARCH
    Advisory Committee for           April 26, May 15-16, November 2-3
     Pharmaceutical Science
    Advisory Committee for           March 28-29, April 10, May 4-5
     Reproductive Health Drugs
    Anesthetic and Life Support      November 6-7
     Drugs Advisory Committee

[[Page 16207]]

 
    Anti-Infective Drugs Advisory    March 24, September 11-12
     Committee
    Antiviral Drugs Advisory         July 20-21
     Committee
    Arthritis Advisory Committee     April 11, June 8-9, September 11-
                                      12, November 9-10
    Cardiovascular and Renal Drugs   May 1-2, July 20-21, October 19-20
     Advisory Committee
    Dermatologic and Ophthalmic      May 4-5
     Drugs Advisory Committee
    Drug Abuse Advisory Committee    October 19-20
    Endocrinologic and Metabolic     May 18-19, July 13-14, October 5-6,
     Drugs Advisory Committee         December 7-8
    Gastrointestinal Drugs Advisory  April 12
     Committee
    Medical Imaging Drugs Advisory   May 22-23, October 30-31
     Committee
    Nonprescription Drugs Advisory   June 22-23, July 13-14, October 19-
     Committee                        20, December 7-8
    Oncologic Drugs Advisory         March 16-17, June 5-6
     Committee
    Peripheral and Central Nervous   October 26
     System Drugs Advisory
     Committee
    Pharmacy Compounding Advisory    May 15-16
     Committee
    Psychopharmacologic Drugs        June 28-29, November 2-3
     Advisory Committee
    Pulmonary-Allergy Drugs          November 6-7
     Advisory Committee
CENTER FOR FOOD SAFETY AND APPLIED
 NUTRITION
    Food Advisory Committee          September 14-15
CENTER FOR DEVICES AND RADIOLOGICAL
 HEALTH
    Device Good Manufacturing        No meetings planned
     Practice Advisory Committee
    Medical Devices Advisory
     Committee
    Anesthesiology and Respiratory   May 25-26, September 7-8, November
     Therapy Devices Panel            2-3
    Circulatory System Devices       May 2-3, September 25-26
     Panel
    Clinical Chemistry and Clinical  March 24, June 29-30, September 14-
     Toxicology Devices Panel         15, December 14-15
    Dental Products Panel            April 6-7, May 23-24, July 18-19,
                                      October 3-4
    Ear, Nose, and Throat Devices     May 26, June 23, July 20-21,
     Panel                            September 22
    Gastroenterology-Urology         April 13-14, August 31-September 1,
     Devices Panel                    November 30-December 1
    General and Plastic Surgery      June 12-13, September 11-12,
     Devices Panel                    December 4-5
    General Hospital and Personal     May 1-2, August 7-8, November 6-7
     Use Devices Panel
    Hematology and Pathology         June 12, August 8, November 7
     Devices Panel
    Immunology Devices Panel         June 16, September 15, December 8
    Medical Devices Dispute          To be determined
     Resolution Panel
    Microbiology Devices Panel       June 21-22, November 16-17
    Molecular and Clinical Genetics  June 23, September 15, December 15
     Panel
    Neurological Devices Panel       March 31, May 11-12, August 17-18,
                                      November 16-17
    Obstetrics-Gynecology Devices    April 10-11, July 24-25, October 9-
     Panel                            10
    Ophthalmic Devices Panel         March 17, May 11-12, July 27-28,
                                      September 21-22, November 8-9
    Orthopaedic and Rehabilitation   March 18, May 4-5, August 24-25,
     Devices Panel                    November 16-17
    Radiological Devices Panel       May 15, August 14, November 6
    National Mammography Quality     July 10, December 11
     Assurance Advisory Committee
    Technical Electronic Product     June 21-22
     Radiation Safety Standards
     Committee
CENTER FOR VETERINARY MEDICINE
    Veterinary Medicine Advisory     September 15
     Committee
NATIONAL CENTER FOR TOXICOLOGICAL
 RESEARCH
      Advisory Committee on Special  No meetings planned
       Studies Relating to the
       Possible Long-Term Health
       Effects of Phenoxy
       Herbicides and Contaminants
    Science Board to the National    May 1-2
     Center for Toxicological
     Research
------------------------------------------------------------------------


    Dated: March 17, 2000.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 00-7429 Filed 3-24-00; 8:45 am]
BILLING CODE 4160-01-F